Skip to content

It looks like we may have content for your preferred language. Would you like to view this page in English?

Cobalt's Generic Boniva Barred in Roche IP Spat

By Megan Stride, Law360
Loeb & Loeb LLP and Mark Waddell are noted as counsel for Hoffmann-La Roche Inc. in the pharmaceutical company's successful bid for preliminary injunction barring Cobalt Pharmaceuticals Inc. from launching a generic version of the branded osteoporosis drug Boniva®.